Inhibition of angiogenesis and invasion in malignant gliomas.
about
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.Therapeutic strategies for inhibiting invasion in glioblastoma.Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4Three-dimensional imaging of the mouse neurovasculature with magnetic resonance microscopyBevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitors.Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cellsAntiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approachesMolecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress.Vascular phenotyping of brain tumors using magnetic resonance microscopy (μMRI).High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma.Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.Angiogenesis as a therapeutic target in malignant gliomas.Biology of angiogenesis and invasion in gliomaAnti-angiogenic therapy in glioma.Towards tailored therapy of glioblastoma multiforme.Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.Molecularly targeted therapies for recurrent glioblastoma: current and future targets.Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.Role for cytotoxic chemotherapy in patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.Antiangiogenesis: biology and utility in the treatment of gliomas.Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure.IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme.
P2860
Q28564217-1F12A94B-82B9-407C-9498-D1372360317EQ33388541-6BB2595C-9DB8-4D22-BC11-0223F64B4D39Q33426563-F439704B-4392-4CAC-9297-912B7802466FQ33618844-6CE362E6-16A5-4B92-BCD1-00447A1D84E5Q33983321-4C915CAF-AA52-400F-A2B4-DE0C9D1D8384Q34132928-A5D1DF48-C466-4A7E-AFAF-9A8D57351781Q34414009-C4B9504F-3CAA-4981-8608-581E40F8A38DQ34515465-962FE989-9355-417A-9E3E-731579760D59Q35054642-8C9B24C5-9F5E-47B4-9924-B6C232F275F6Q35108532-5A69EE1A-19C9-48B0-A126-74075E07864CQ36112656-345A068C-72F0-40F3-B8FE-0E2B73C09C51Q37395361-C7F5715A-3056-4B02-B014-2E306016A4BBQ37504362-3ABC3BC7-BFBE-4675-8CCB-61C3884E82D3Q37533625-7BE45056-908D-4A5C-95C1-3E482E14E6D9Q37877409-70DAB423-819B-4D1C-98C7-569E9A8B8A62Q37908815-8CE7016C-1D1F-43A2-8004-D0379D0554F8Q38021521-04A8DD27-0360-4612-B5A9-5C4B128248E2Q38272728-D50B738E-3CE6-425C-86FF-F648A26508CFQ39360710-FBB4BEDA-74BE-4AF1-A422-B58F1D70F09EQ48365671-5881778A-D1E0-4583-8B32-2B6FAFE736B7Q48876380-31A83F73-4F4A-4841-BA69-7CF29BF11EECQ54626874-EB733817-AA39-425A-BF23-11F26D23AB61Q55363441-922861A6-8CB9-4DFF-AADF-125669DCD772
P2860
Inhibition of angiogenesis and invasion in malignant gliomas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Inhibition of angiogenesis and invasion in malignant gliomas.
@en
Inhibition of angiogenesis and invasion in malignant gliomas.
@nl
type
label
Inhibition of angiogenesis and invasion in malignant gliomas.
@en
Inhibition of angiogenesis and invasion in malignant gliomas.
@nl
prefLabel
Inhibition of angiogenesis and invasion in malignant gliomas.
@en
Inhibition of angiogenesis and invasion in malignant gliomas.
@nl
P2093
P2860
P1476
Inhibition of angiogenesis and invasion in malignant gliomas.
@en
P2093
Andrew Chi
Andrew D Norden
Patrick Y Wen
P2860
P304
P356
10.1586/14737140.7.11.1537
P577
2007-11-01T00:00:00Z